Radioactive sugar tracer reveals hidden metabolic pathways in obesity

NCT ID NCT07690176

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study investigates how the body processes glucose after a high-sugar meal in lean individuals and those with obesity. Participants drink a tiny, safe amount of radioactive glucose so researchers can trace exactly where the sugar goes—into breath, urine, or stool—and measure whether a lesser-known pathway (the polyol pathway) is more active in obesity. The goal is to understand fundamental differences in glucose metabolism that could explain why obesity increases the risk of diabetes and other metabolic disorders.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
low-glycemic breakfast with 14C-glucose microtracer
What this could lead to
If successful, this could reveal why obesity alters glucose processing, potentially pointing to new targets for managing or preventing metabolic disease.
What could go wrong
This is a small, early-stage observational study (24 people) that measures metabolic pathways, not clinical outcomes. Results may not apply to broader populations or lead directly to treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Wageningen University and Research

    RECRUITING

    Wageningen, 6708 WD, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.